Brain Tumours FAQs
Your Medical and Research questions answered
Yes. Brain tumours are divided into four classifications – grades 1 and 2 are low-grade, grades 3 and 4 are classed as high-grade. High-grade or malignant brain tumours are aggressive and can spread quickly in the brain and are usually a serious threat to life. Low-grade or benign brain tumours are slower-growing and not usually immediately life threatening but can still have a potentially dangerous impact on a person’s wellbeing. These tumours can become high-grade over time.
There are more than 120 different types of brain tumour and in the majority of cases it is not known what causes them. Brain tumours are indiscriminate; they can affect anyone at any age. Approximately 18,000 people are diagnosed with a brain tumour every year.
Some risk factors have been identified, but due to the complex and unique health history for each patient, scientists are still unable to answer this fundamental question of why a brain tumour has appeared. Like all tumours and cancers, mutations in the DNA of a cell leads to abnormal growth (uncontrolled division), and as further mutations accumulate so the tumour can invade surrounding brain cells, but what causes these mutations is likely to vary between individuals.
In the UK, 18,000 people each year are diagnosed with a brain tumour. Brain cancer is still classed as a rare cancer. There are more than 120 different types of brain tumour so each sub-type of the disease is relatively rare.
In most cases, yes. The specialist clinicians involved in diagnosing and advising on treatment will suggest different options for different patients, depending on tumour type, low or high-grade, location of the tumour in the brain, age and health of patient. Treatment options include surgery, radiotherapy and chemotherapy.
Currently, just 12% of people diagnosed with a brain tumour survive beyond five years of their diagnosis, compared with an average of 50% across all cancers.
Yes, according to Cancer UK (extracted 1.7.2021):
• Since the early 1990s, brain, other CNS (central nervous system) and intracranial tumours incidence rates have increased by 39% in the UK. Rates in females have increased by half and rates in males have increased by more than a quarter (27%) (2015-2017).
• Over the last decade, brain, other CNS and intracranial tumours incidence rates have increased by around 15% in the UK. Rates in females have increased by more than a fifth (22%), and rates in males have increased by almost a tenth (8%) (2015-2017).
• Incidence rates for brain tumours are projected to rise by 6% in the UK between 2014 and 2035, to 22 cases per 100,000 people by 2035.
There is evidence that, in a very small number of cases, inherited genetic factors or conditions have contributed to the development of a brain tumour. These conditions include Li-Fraumeni syndrome, neurofibromatosis, nevoid basal cell carcinoma syndrome, tuberous sclerosis, Turcot syndrome, and von Hippel-Lindau disease.
Scientists have also found ‘clusters’ of brain tumours within some families without a link to these known hereditary conditions. Studies are underway to try to understand more.
No, a brain tumour occurs as a result of an abnormal growth or spread of cells from within the brain or its supporting tissues that can damage the brain or threaten its function. You cannot spread a brain tumour by contact.
The symptoms of a brain tumour will depend upon which part of the brain is affected. The most common symptoms are caused by an increase in pressure in the skull (intracranial pressure) caused by the growth of a tumour in the brain.
Symptoms may include at least two of the following (symptoms on their own can be indicative of something else – if you are worried you should consult your GP):
• Severe or persistent headaches
• Loss or changes to vision
• Continuing nausea, vomiting
• Extreme or sudden drowsiness
• Tinnitus (ringing in the ears) or hearing loss
• Unexplained twitches of the face or limbs
• Seizures (fits or faints)
• Appearing to be lost in a deep daydream for a short while
• Confusion
• Loss of balance
• Numbness or weakness in the arms or legs, especially if progressive and leading to paralysis
• Numbness or weakness in a part of the face, so that the muscles drop slightly
• Numbness or weakness on one side of the body, resulting in stumbling or lack of co-ordination
• Changes in personality or behaviour
• Impaired memory or mental ability, which may be very subtle to begin with
• Changes in senses, including smell
• Problems with speech, writing or drawing
• Loss of concentration or difficulty in concentrating
• Changes in sleep patterns
Neurosurgery is usually the first step in treatment for most types of brain tumours, and is often called a resection, and can be full or partial. The aim is to remove as much of the tumour as possible whilst avoiding any damage to other parts of the brain. In some instances, surgery may be deemed too high risk due to the location of the tumour in the brain which makes it very difficult or impossible to reach without damaging other healthy parts of the brain, or if it is near a blood vessel that may be damaged.
Radiotherapy for brain tumours is the use of high-energy radiation to destroy cancer cells. Radiotherapy is used instead of surgery when an operation is not possible, or after surgery in order to kill as many cancerous cells as possible, which may not have been able to be removed during the operation. Radiotherapy is usually successful at shrinking brain tumours. This is one of the main aims of the treatment because by shrinking the tumour, the pressure inside the skull is reduced and hence symptoms may improve.
Chemotherapy consists of drugs, most commonly taken either in tablet form or as a liquid infused into the veins during a hospital visit. Sometimes chemotherapy is used alone to treat some types of brain tumour, but it is more commonly prescribed after surgery and/or radiotherapy has reduced the tumour size.
Other treatment options may include immunotherapy and clinical trials.
The prognosis – impact on wellbeing and threat to life – is mainly dependent on the type of tumour, location in the brain, tumour size at time of diagnosis, growth and how much can be removed or successfully treated. Factors including patient age and general health also have a bearing, as well as some recognised genetic factors.
High-grade or malignant brain tumours are aggressive and can spread quickly in the brain and are usually a serious threat to life. A grade 3 or 4 tumour usually comes back after treatment even if it appears to have been completely eradicated the first time. This is because of its invasive nature; the ability to spread its tumour-forming cells to other parts of the brain or spinal cord.
Low-grade or benign brain tumours are slower-growing and not usually immediately life threatening but can still have a potentially dangerous impact on a person’s wellbeing. Grade 1 tumours are usually well treated and carry a good prognosis.
Whilst a CT scan can show the size, shape and location of a brain tumour, an MRI scan is then required in order to gain more detailed information.
There are over 120 different types of brain tumour, each of which have their own characteristics. More information on the different types and categories of brain tumours can be found here: www.braintumourresearch.org/info-support/types-of-brain-tumour
Brain Tumour Awareness Month takes place in the UK during March each year.
If you are worried you or a loved one may have a brain tumour, visit your GP as soon as possible. Write down your symptoms and include a timeline that shows when each one began, and how frequently they occur. If your doctor suspects the presence of a brain tumour, they will refer you for a scan at a hospital in order to be sure whether or not one is present.
Some of our fellow charities have a helpline for patients and families of those touched with a brain tumour.
Brainstrust supports patients at the point of diagnosis, or at any point on this journey. They give practical advice about what you can do to take control of the situation, whether you are the person diagnosed with a brain tumour or a caring friend or relative. www.brainstrust.org.uk
The Brain & Spine Foundation helpline is a service run by neuroscience nurses. The helpline covers all brain and spine conditions from common to the very rare and can offer information and support on any medical or related social and emotional issues of concern. www.brainandspine.org.uk
Brain Tumour Action provides support, education, training and research for patients, relatives and professionals throughout the UK. The charity runs a Helpline which is open 24 hours a day and is manned by a trained counsellor. www.braintumouraction.org.uk
By fundraising to support brain tumour research charities like In Sue’s Name which are focused on finding a cure, sharing your story to help raise awareness and campaigning with us to lobby government to increase the national investment in this devastating disease.